Real-Life Experience of Using Brinzolamide/Brimonidine Fixed Drop Combination in a Tertiary Glaucoma Centre

International Ophthalmology - Netherlands
doi 10.1007/s10792-019-01194-6
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fixed-Combination Brinzolamide 1%/Brimonidine 0.2% vs Monotherapy With Brinzolamide or Brimonidine in Patients With Open-Angle Glaucoma or Ocular Hypertension: Results of a Pooled Analysis of Two Phase 3 Studies

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Clinical Effectiveness of Brinzolamide 1%–brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension

Clinical Ophthalmology
Ophthalmology
2015English

Brinzolamide/Brimonidine Fixed-Dose Combination Bid as an Adjunct to a Prostaglandin Analog for Open-Angle Glaucoma/Ocular Hypertension

European Journal of Ophthalmology
MedicineOphthalmology
2019English

Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil☆

Clinical Therapeutics
Pharmacology
2020English

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

Clinical Ophthalmology
Ophthalmology
2011English

Fixed Combination Therapies in Glaucoma

2015English

A Comparative Study on Safety and Efficacy of Travoprost and Brimonidine/Timolol Fixed Combination in Patients of Primary Open Angle Glaucoma

International Journal of Basic and Clinical Pharmacology
2015English

Preliminary Results Following the Use of a Fixed Combination of Timolol–brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Clinical Ophthalmology
Ophthalmology
2009English

Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy